Redefining the Standard of Care: The PROGRESS Trial Challenges the "Wait and See" Approach to Moderate Aortic Stenosis on November 3, 2026 Posted by
Decoding the Immune Stalemate: A New Frontier in Treating Chronic Diabetic Ulcers on November 3, 2026 Posted by
NewYork-Presbyterian and Spear Forge Landmark Partnership to Revolutionize Outpatient Rehabilitation Access Across NYC and Westchester on November 3, 2026 Posted by
Beyond the Salt Shaker: Why Potassium is the Missing Link in Global Heart Health on November 3, 2026 Posted by
Navigating the Future of Nutrition: A Comprehensive Review of the 2022-2023 Healthy Living Landscape on November 3, 2026 Posted by
Redefining the Standard of Care: The PROGRESS Trial Challenges the "Wait and See" Approach to Moderate Aortic Stenosis on November 3, 2026 Posted by
Decoding the Immune Stalemate: A New Frontier in Treating Chronic Diabetic Ulcers on November 3, 2026 Posted by
NewYork-Presbyterian and Spear Forge Landmark Partnership to Revolutionize Outpatient Rehabilitation Access Across NYC and Westchester on November 3, 2026 Posted by
Posted in Medical Innovations A High-Stakes Gamble: Capricor Therapeutics and the Murky Future of Deramiocel on August 20, 2026
Posted in Medical Innovations The Fragility of Hope: Inside the FDA’s Contentious Advisory Panel on Capricor’s Duchenne Therapy on July 30, 2026
Posted in Digital Health Tools Biotech Turmoil: Capricor Therapeutics Files Suit Against Partner Over Duchenne Therapy Launch on May 10, 2026 rifanmuazin
Posted in Digital Health Tools Legal Showdown: Capricor Therapeutics Sues Partner Over “Fatal Flaw” in Duchenne Therapy Rollout on May 9, 2026 rifanmuazin
